1. Home
  2. ACCO vs ALDX Comparison

ACCO vs ALDX Comparison

Compare ACCO & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACCO
  • ALDX
  • Stock Information
  • Founded
  • ACCO 1893
  • ALDX 2004
  • Country
  • ACCO United States
  • ALDX United States
  • Employees
  • ACCO N/A
  • ALDX N/A
  • Industry
  • ACCO Publishing
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACCO Consumer Discretionary
  • ALDX Health Care
  • Exchange
  • ACCO Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • ACCO 350.6M
  • ALDX 326.6M
  • IPO Year
  • ACCO N/A
  • ALDX 2014
  • Fundamental
  • Price
  • ACCO $4.02
  • ALDX $5.81
  • Analyst Decision
  • ACCO Buy
  • ALDX Strong Buy
  • Analyst Count
  • ACCO 1
  • ALDX 2
  • Target Price
  • ACCO $6.00
  • ALDX $9.50
  • AVG Volume (30 Days)
  • ACCO 610.2K
  • ALDX 944.6K
  • Earning Date
  • ACCO 07-31-2025
  • ALDX 08-07-2025
  • Dividend Yield
  • ACCO 7.65%
  • ALDX N/A
  • EPS Growth
  • ACCO N/A
  • ALDX N/A
  • EPS
  • ACCO 0.49
  • ALDX N/A
  • Revenue
  • ACCO $1,581,200,000.00
  • ALDX N/A
  • Revenue This Year
  • ACCO N/A
  • ALDX N/A
  • Revenue Next Year
  • ACCO $2.11
  • ALDX $43.00
  • P/E Ratio
  • ACCO $8.19
  • ALDX N/A
  • Revenue Growth
  • ACCO N/A
  • ALDX N/A
  • 52 Week Low
  • ACCO $3.32
  • ALDX $1.14
  • 52 Week High
  • ACCO $6.44
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • ACCO 62.73
  • ALDX 71.16
  • Support Level
  • ACCO $3.82
  • ALDX $5.34
  • Resistance Level
  • ACCO $3.94
  • ALDX $5.73
  • Average True Range (ATR)
  • ACCO 0.11
  • ALDX 0.27
  • MACD
  • ACCO 0.03
  • ALDX 0.01
  • Stochastic Oscillator
  • ACCO 94.78
  • ALDX 77.36

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: